Scientists grow new corneas in lab to restore sight
NCT ID NCT04319848
Summary
This early-stage trial is testing whether a lab-grown corneal graft made from human cells is safe and effective for treating vision loss caused by corneal diseases like Fuchs' dystrophy. The study will enroll 30 adults with mild to moderate corneal damage to receive the engineered tissue graft. Researchers will monitor patients' vision, eye pressure, and check for complications over time to see if this approach can help restore sight without using donor corneas.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FUCHS' ENDOTHELIAL DYSTROPHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Singapore Eye Research Institute
RECRUITINGSingapore, Singapore
Contact
Conditions
Explore the condition pages connected to this study.